UNSPSC 51282533: Cefmepidium chloride

This classification denotes a cephalosporin antibiotic with the molecular formula C23H25N6O8S3.Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 726233N8L3, chemically known as 4-((((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)thio)-1-methylpyridinium chloride 7,2-(z)-(o-(1-carboxy-1-methylethyl)oxime) s-oxide. but more generally known as cefmepidium chloride, which bears US NIH Compound Identifier 9589472.

UNSPSC 51282533 Cefmepidium chloride is a Commodity code for a specific pharmaceutical active ingredient, but recent state and local solicitation activity under this code does not align with its nominal scope. The source shows no open or awarded opportunities for cefmepidium chloride itself. The two most recent records tagged to this code document a completed pharmaceutical warehouse award by the Illinois Department of Public Health (Doxycycline Hyclate and Ciprofloxacin Hydrochloride through Chartwell Rx LLC under MMCAP Infuse cooperative purchasing) and a Seminole County, Florida IFB for naloxone and drug deactivation systems — neither of which involves cefmepidium chloride as a procured item. The mismatch suggests that state and local procurement systems may be applying this code to broader pharmaceutical supply categories rather than to cefmepidium chloride specifically, or that the code has limited direct activity.

Geographic activity appears concentrated in the Southeast and Midwest, with the Illinois Department of Public Health and Seminole County, Florida as the recent issuing bodies. No additional jurisdictions are identified in the source. The Illinois procurement was a completed award (closed August 28, 2026) with a total value of $2,999,999.11 over the initial 12-month term plus two renewal options; Seminole County's IFB sought 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries and a due date of July 26, 2023. Given the absence of live solicitation opportunities directly aligned with cefmepidium chloride and the misalignment between the code's nominal scope and what recent opportunities actually procure, pursue or watch decisions should be grounded in clarification of how your target agencies apply this code internally.